Fischer, F.* et al. Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis. Virol. J. 21:139 (2024)
Orabi, A.* ; Shameli, K.* ; Protzer, U. & Moeini, H.* Adenoviral fiber-knob based vaccination elicits efficient neutralizing antibodies and T cell responses against adenovirus infection. Virol. J. 21:246 (2024)
Kroidl, I.* et al. Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison. Virol. J. 20:200 (2023)
Vincendeau, M. ; Nagel, D. ; Brenke, J.K. ; Brack-Werner, R. & Hadian, K. Heterogenous nuclear ribonucleoprotein Q increases protein expression from HIV-1 Rev-dependent transcripts. Virol. J. 10:151 (2013)
Ruiss, R. ; Ohno, S. ; Steer, B. ; Zeidler, R.* & Adler, H. Murine gammaherpesvirus 68 glycoprotein 150 does not contribute to latency amplification in vivo. Virol. J. 9:107 (2012)
Masanetz, S. & Lehmann, M.H. HIV-1 Nef increases astrocyte sensitivity towards exogenous hydrogen peroxide. Virol. J. 8:35 (2011)
Schildgen, V. ; Ziegler, S.* ; Tillmann, R.L.* & Schildgen, O.* Novel mutation in YMDD motif and direct neighbourhood in a child with chronic HBV-infection and clinical lamivudine and adefovir resistance - a scholarly case. Virol. J. 7:167 (2010)